Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Retained Earnings (2016 - 2025)

CorMedix's Retained Earnings history spans 13 years, with the latest figure at $3000.0 for Q4 2025.

  • For Q4 2025, Retained Earnings rose 100.0% year-over-year to $3000.0; the TTM value through Dec 2025 reached $3000.0, up 100.0%, while the annual FY2025 figure was $3000.0, 100.0% up from the prior year.
  • Retained Earnings for Q4 2025 was $3000.0 at CorMedix, up from -$190.6 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $101232.0 in Q1 2023 and bottomed at -$353.1 million in Q3 2024.
  • The 5-year median for Retained Earnings is $45772.0 (2022), against an average of -$117.5 million.
  • The largest YoY upside for Retained Earnings was 102.78% in 2023 against a maximum downside of 670697.71% in 2023.
  • A 5-year view of Retained Earnings shows it stood at -$245.7 million in 2021, then skyrocketed by 100.03% to $82743.0 in 2022, then crashed by 371063.08% to -$306.9 million in 2023, then decreased by 10.65% to -$339.6 million in 2024, then surged by 100.0% to $3000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Retained Earnings are $3000.0 (Q4 2025), -$190.6 million (Q3 2025), and -$299.2 million (Q2 2025).